Science Inventory

Category-based toxicokinetic evaluations of per- and polyfluoroalkyl substances (PFAS) for new approach method (NAM) application

Citation:

Wetmore, B. Category-based toxicokinetic evaluations of per- and polyfluoroalkyl substances (PFAS) for new approach method (NAM) application. SOT, Salt Lake City, UT, March 10 - 14, 2024. https://doi.org/10.23645/epacomptox.25395481

Impact/Purpose:

N/A

Description:

Concern over exposure to and potential health effects of per- and polyfluoroalkyl substances (PFAS) continues to increase as more is learned about their environmental persistence and human bioaccumulative potential. With PFAS estimates ranging to over 10,000, the limited exposure and toxicologic data currently available is inadequate to provide an understanding of the potential exposures, toxicokinetics (TK), and toxicities across this diverse domain. New approach methods (NAMs) use in vitro high-throughput screening (HTS) to assess potential effects and require the incorporation of in vitro TK data to translate bioactive in vitro assay concentrations to an administered equivalent dosage (AED) necessary for chemical risk evaluations. To address this need, NAM TK data have been generated on over 100 PFAS, selected primarily to facilitate category-based read-across and capture structural diversity. TK plasma protein binding measures for PFAS showed much higher binding than is typical for non-PFAS commercial chemicals, with median fraction unbound in plasma (fup) values of 0.023 vs. 0.13, respectively. The highest binding was observed for perfluorocarboxylates, perfluoroalkanoyl chlorides, and perfluoropolyether carboxylates. High binding generally increases tissue distribution, reduces renal elimination, and decreases rate of metabolism. Measured human hepatic clearance rates were minimal for most, with metabolism noted primarily for PFAS alcohols, amides, and sulfonamides. Efforts incorporating TK to predict AEDs for HTS data demonstrate that PPB differences drive the range of values derived, with legacy PFAS remaining those with the highest systemic concentrations after exposure. These findings and other considerations regarding the utility of a NAM read-across approach to estimate risk for the broader untested PFAS domain will be discussed. This abstract does not necessarily reflect EPA policy.

Record Details:

Record Type:DOCUMENT( PRESENTATION/ SLIDE)
Product Published Date:03/14/2024
Record Last Revised:03/12/2024
OMB Category:Other
Record ID: 360700